Bloomsburg-Berwick sees 43,900 nonfarm payroll employees in November

Bloomsburg-Berwick sees 43,900 nonfarm payroll employees in November
0Comments

The number of employees on nonfarm payrolls for November in Pennsylvania’s Bloomsburg-Berwick metropolitan statistical area was 43,900, according to the U.S. Bureau of Labor Statistics.

Pennsylvania reported 5.9 million people employed on nonfarm payrolls during that same time period.

Statistics were compiled from reports from the civilian labor force and unemployment data, both of which heavily relied on household surveys. The data is not seasonally adjusted.

Employment data is gleaned from an establishment survey measures nonfarm employment, hours and earnings by industry. The data is also based on payroll jobs and such factors as where the establishments are located.

Pennsylvania Employees on Nonfarm Payrolls

October 2021 (In thousands) November 2021 (In thousands) Percent Change by Month
43.7 43.9 0.5%

Source: Bureau of Labor Statistics



Related

Camera Bartolotta, State Senator for Pennsylvania

Pennsylvania State Senator Bartolotta on child abductions: ‘Every second matters when a child is abducted’

State Senator Camera C. Bartolotta announced new legislative measures aimed at improving law enforcement response times during child abductions and strengthening commercial driver safety standards across Pennsylvania.

Doug Mastriano, State Senator for Pennsylvania

Pennsylvania Sen. Mastriano on property tax relief proposal: ‘There should come a time when that obligation ends’

State Sen. Doug Mastriano announced new legislation aimed at providing full property tax relief for long-term elderly homeowners in Pennsylvania.

Jennifer Riley, Executive Director, Patients Come First - Pennsylvania

PA Patients Come First Executive Director on healthcare policy: PBM reform and accountability are central to the ‘healthcare experience of Pennsylvanians’

Jennifer Riley of Patients Come First called for greater attention from Pennsylvania policymakers on PBM reform and accountability within the federal 340B drug pricing program.